Literature DB >> 2816557

The presentation and management of pituitary tumours in the elderly.

D L Cohen1, J S Bevan, C B Adams.   

Abstract

Twenty-two patients presenting with pituitary tumours (16 non-functioning) after the age of 70 years were identified in a review of all patients assessed in Oxford hospitals between 1982 and 1986. They were matched with younger patients, to compare modes of presentation and treatment outcome. Younger patients presented more commonly than elderly with symptoms of deficiency of adrenocorticotrophic hormone, thyroid-stimulating hormone or gonadotrophin, although the prevalence of biochemical deficiency was similar in the two groups. Trans-sphenoidal adenomectomy was performed on 12 elderly patients with visual impairment. Of those with field loss, seven improved, one was unchanged and two deteriorated after surgery, though one of the last was improved by haematoma evacuation, and two cranial nerve palsies resolved. There were no other peri-operative complications in the elderly. Transsphenoidal surgery is the treatment of choice for non-functioning tumours causing visual failure; it decompresses the adenoma with minimal morbidity and endocrine impairment, and is well tolerated by elderly patients.

Entities:  

Mesh:

Year:  1989        PMID: 2816557     DOI: 10.1093/ageing/18.4.247

Source DB:  PubMed          Journal:  Age Ageing        ISSN: 0002-0729            Impact factor:   10.668


  9 in total

1.  The epidemiology of prolactinomas.

Authors:  Antonio Ciccarelli; Adrian F Daly; Albert Beckers
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

2.  Impact of etiology, age and gender on onset and severity of hyponatremia in patients with hypopituitarism: retrospective analysis in a specialised endocrine unit.

Authors:  Dragana Miljic; Mirjana Doknic; Marko Stojanovic; Marina Nikolic-Djurovic; Milan Petakov; Vera Popovic; Sandra Pekic
Journal:  Endocrine       Date:  2017-09-14       Impact factor: 3.633

3.  Pituitary adenomas in elderly patients: clinical and surgical outcome analysis in a large series.

Authors:  Alfio Spina; Marco Losa; Pietro Mortini
Journal:  Endocrine       Date:  2019-06-17       Impact factor: 3.633

4.  Invasive adenoma and pituitary carcinoma: a SEER database analysis.

Authors:  Tara M Hansen; Sachin Batra; Michael Lim; Gary L Gallia; Peter C Burger; Roberto Salvatori; Gary Wand; Alfredo Quinones-Hinojosa; Lawrence Kleinberg; Kristin J Redmond
Journal:  Neurosurg Rev       Date:  2014-02-14       Impact factor: 3.042

5.  Transsphenoidal surgical treatment of pituitary adenomas in patients aged 80 years or older.

Authors:  Shunji Yunoue; Hiroshi Tokimura; Atsushi Tominaga; Shingo Fujio; Prasanna Karki; Satoshi Usui; Yasuyuki Kinoshita; Mika Habu; F M Moinuddin; Hirofumi Hirano; Kazunori Arita
Journal:  Neurosurg Rev       Date:  2013-11-15       Impact factor: 3.042

6.  A retrospective analysis on biochemical parameters, cardiovascular risk and cardiomyopathy in elderly acromegalic patients.

Authors:  A Colao; R Pivonello; L Spinelli; M Galderisi; R S Auriemma; M Galdiero; G Vitale; M De Leo; G Lombardi
Journal:  J Endocrinol Invest       Date:  2007-06       Impact factor: 4.256

7.  Surgical management of pituitary adenomas: does age matter?

Authors:  Valentina Tardivo; Federica Penner; Diego Garbossa; Giuseppe Di Perna; Paolo Pacca; Luca Salvati; Roberto Altieri; Silvia Grottoli; Francesco Zenga
Journal:  Pituitary       Date:  2020-04       Impact factor: 4.107

8.  Surgical treatment of pituitary tumors in the elderly: clinical outcome and long-term follow-up.

Authors:  Luigi Ferrante; Giuseppe Trillò; Epimenio Ramundo; Paolo Celli; Marie-Lise Jaffrain-Rea; Maurizio Salvati; Vincenzo Esposito; Raffaele Roperto; Mattia Falchetto Osti; Giuseppe Minniti
Journal:  J Neurooncol       Date:  2002-11       Impact factor: 4.130

9.  Impact of age on postsurgical outcomes of nonfunctioning pituitary adenomas.

Authors:  E Biamonte; N Betella; D Milani; G B Lasio; S Ariano; S Radice; E Lavezzi; G Mazziotti; A Lania
Journal:  Endocrine       Date:  2020-11-26       Impact factor: 3.633

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.